CoChat
Sign Up
Cited by 80Cutaneous Melanoma Detection and ManagementTelemedicine and Telehealth ImplementationAI in cancer detection

An evaluation of the role of a store-and-forward teledermatology system in skin cancer diagnosis and management

Mahendran, R., Goodfield, M. J. D., Sheehan-Dare, R. A.·2005·Clinical and Experimental Dermatology
DOI 10.1111/j.1365-2230.2005.01735.x
Open this paper in CoChat — free account

Abstract

There is currently much interest in the potential role of telemedicine in improving the delivery of dermatological care in the UK. The two teledermatology systems available at present are divided into live video and store-and-forward technology. We investigated the value of a store-and-forward teledermatology system in the diagnosis and management of lesions suspicious of skin cancer. A total of 163 store-and-forward referrals of patients with one lesion each were assessed independently by a Consultant and a third-year trainee dermatologist. The accuracy of diagnosis and appropriateness of management from these assessments was compared to a subsequent face-to-face consultation with the Consultant. Analysis of the Consultants' diagnoses showed that 48% were identical for teledermatology and conventional face-to-face consultations. A further 17% of teledermatology diagnoses included the actual clinical diagnosis as a possibility but 20% were either incorrect or a diagnosis could not be made. In the remaining 15% of cases the digital image was of insufficient quality for assessment. Of the trainee's reports, 44% were identical to the clinical diagnoses and another 20% included the clinical diagnosis as a possibility. The management plan was appropriate in 55% of the total teledermatology referrals assessed by the Consultants and in 52% assessed by the trainee when compared with the conventional consultation. This study illustrates that the store-and forward type telemedicine system has limited diagnostic accuracy for skin lesions. However, our results suggest that store-and-forward teledermatology may be suitable and safe for screening out clearly benign lesions but the study casts doubt on its efficiency.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2230.2005.01735.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • One of the most active areas for teledermatology development and deployment has been in skin cancer screening, diagnosis, and treatment management.

    “One of the most active areas for teledermatology development and deployment has been in skin cancer screening, diagnosis, and treatment management [44].”

    From Recent directions in telemedicine: Review of trends in research and practice (2015) · cites this paper as [44]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Mahendran, R., Goodfield, M. J. D., & Sheehan-Dare, R. A.
Affiliations
Leeds General Infirmary (GB)
Corresponding author
Mahendran, R.
Venue
Clinical and Experimental Dermatology
Publisher
Oxford University Press (OUP)
Published
2005-05
Volume
30
Issue
3
Pages
209-214
ISSN
  • 0307-6938 (ISSN-L)
  • 1365-2230
DOI
10.1111/j.1365-2230.2005.01735.x
OpenAlex
W2050115096
Cited by
80
References
14
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2018: 8 · 2017: 6 · 2016: 2 · 2015: 6 · 2014: 6 · 2013: 2 · 2012: 3
FWCI
2.95
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3775 d)
Locations
  • Clinical and Experimental Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Government of the United Kingdom
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
Keywords
store-and-forward teledermatology, skin cancer diagnosis, suspicious skin lesions, diagnostic accuracy, telemedicine, digital image quality
MeSH terms
Clinical Competence, Dermatology, England, Family Practice, Humans, Referral and Consultation, Skin Neoplasms, Technology Assessment, Biomedical, Reproducibility of Results, Telemedicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review